Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)

SHE:300653 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	370.72	362.93	413.35	432.95	399.9	293.26
Other Revenue	0.29	0.29	0.3	0.27	0.28	0.02
Revenue	371.01	363.23	413.65	433.22	400.18	293.28
Revenue Growth (YoY)	-5.88%	-12.19%	-4.52%	8.26%	36.45%	4.82%
Cost of Revenue	53.3	46.13	42.98	49.87	44.42	23.27
Gross Profit	317.71	317.09	370.67	383.35	355.75	270.01
Selling, General & Admin	158.81	146.65	132.04	145.55	151.39	125.29
Research & Development	41.82	39.52	44.05	37.55	35.18	26.57
Other Operating Expenses	4.23	3.9	3.86	3.87	3.93	2.14
Operating Expenses	205.29	190.47	180	187.24	190.84	154.52
Operating Income	112.42	126.63	190.68	196.12	164.91	115.5
Interest Expense	-0.02	-0.01	-0.01	-0	-	-
Interest & Investment Income	12.14	13.38	18.9	10.9	1.72	4.25
Other Non Operating Income (Expenses)	-0.21	-0.21	-0.34	0.19	-0.04	0.05
EBT Excluding Unusual Items	124.33	139.78	209.23	207.21	166.59	119.8
Gain (Loss) on Sale of Investments	4.1	5.43	7.3	-2.79	15.94	6.89
Gain (Loss) on Sale of Assets	-	-	0.02	-0.92	-	-
Asset Writedown	-0.08	-0.08	-0.12	-0.11	-0.19	-0.16
Other Unusual Items	7.27	7.24	1.97	8.73	9.23	9.96
Pretax Income	135.62	152.38	218.4	212.11	191.58	136.48
Income Tax Expense	14.73	17.74	27.44	26.67	23.03	18.15
Net Income	120.88	134.64	190.96	185.44	168.55	118.33
Net Income to Common	120.88	134.64	190.96	185.44	168.55	118.33
Net Income Growth	-32.06%	-29.49%	2.98%	10.02%	42.44%	10.20%
Shares Outstanding (Basic)	178	180	180	145	179	179
Shares Outstanding (Diluted)	178	180	180	145	179	179
Shares Change (YoY)	-1.94%	-0.35%	24.35%	-19.21%	0.01%	-0.94%
EPS (Basic)	0.68	0.75	1.06	1.28	0.94	0.66
EPS (Diluted)	0.68	0.75	1.06	1.28	0.94	0.66
EPS Growth	-30.72%	-29.24%	-17.19%	36.17%	42.42%	11.24%
Free Cash Flow	139.33	135.81	148.6	131.78	156.31	15.41
Free Cash Flow Per Share	0.78	0.76	0.82	0.91	0.87	0.09
Dividend Per Share	0.460	0.460	0.802	0.600	0.587	0.167
Dividend Growth	-42.63%	-42.63%	33.63%	2.27%	251.95%	-49.98%
Gross Margin	85.63%	87.30%	89.61%	88.49%	88.90%	92.07%
Operating Margin	30.30%	34.86%	46.10%	45.27%	41.21%	39.38%
Profit Margin	32.58%	37.07%	46.16%	42.80%	42.12%	40.35%
Free Cash Flow Margin	37.55%	37.39%	35.92%	30.42%	39.06%	5.25%
EBITDA	134.85	148.68	211.19	215.22	182.65	121.67
EBITDA Margin	36.35%	40.93%	51.06%	49.68%	45.64%	41.49%
D&A For EBITDA	22.43	22.05	20.52	19.1	17.74	6.18
EBIT	112.42	126.63	190.68	196.12	164.91	115.5
EBIT Margin	30.30%	34.86%	46.10%	45.27%	41.21%	39.38%
Effective Tax Rate	10.87%	11.64%	12.56%	12.57%	12.02%	13.30%
Revenue as Reported	371.01	363.23	413.65	433.22	400.18	293.28
Advertising Expenses	-	4.19	3.33	4.06	5.11	4.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.